Evaluating the Ups and Downs of Geovax Labs Inc’s (GOVX) Stock

In the past week, GOVX stock has gone up by 13.38%, with a monthly decline of -19.90% and a quarterly plunge of -45.77%. The volatility ratio for the week is 10.23%, and the volatility levels for the last 30 days are 10.67% for Geovax Labs Inc The simple moving average for the past 20 days is 0.37% for GOVX’s stock, with a -70.87% simple moving average for the past 200 days.

Is It Worth Investing in Geovax Labs Inc (NASDAQ: GOVX) Right Now?

Additionally, the 36-month beta value for GOVX is 2.71. There are mixed opinions on the stock, with 0 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”

The public float for GOVX is 2.27M and currently, short sellers hold a 0.28% ratio of that float. The average trading volume of GOVX on May 06, 2024 was 39.97K shares.

GOVX) stock’s latest price update

Geovax Labs Inc (NASDAQ: GOVX)’s stock price has gone rise by 13.38 in comparison to its previous close of 1.42, however, the company has experienced a 13.38% increase in its stock price over the last five trading days. GlobeNewsWire reported 2024-03-28 that ATLANTA, GA, March 28, 2024 (GLOBE NEWSWIRE) — via NewMediaWire – GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and infectious diseases, today announced that its Chief Scientific Officer, Mark Newman, PhD, will present data on GEO-CM04S1, the Company’s next-generation Covid-19 vaccine candidate, during the upcoming 24th Annual World Vaccine Congress taking place in Washington, DC on April 1-4, 2024.

Analysts’ Opinion of GOVX

Many brokerage firms have already submitted their reports for GOVX stocks, with Maxim Group repeating the rating for GOVX by listing it as a “Buy.” The predicted price for GOVX in the upcoming period, according to Maxim Group is $8 based on the research report published on November 19, 2020 of the previous year 2020.

GOVX Trading at -15.58% from the 50-Day Moving Average

After a stumble in the market that brought GOVX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -86.04% of loss for the given period.

Volatility was left at 10.67%, however, over the last 30 days, the volatility rate increased by 10.23%, as shares sank -14.81% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -26.48% lower at present.

During the last 5 trading sessions, GOVX rose by +13.38%, which changed the moving average for the period of 200-days by -81.14% in comparison to the 20-day moving average, which settled at $1.5900. In addition, Geovax Labs Inc saw -70.27% in overturn over a single year, with a tendency to cut further losses.

Insider Trading

Reports are indicating that there were more than several insider trading activities at GOVX starting from DODD DAVID A, who purchase 8,209 shares at the price of $2.27 back on Feb 22 ’24. After this action, DODD DAVID A now owns 18,661 shares of Geovax Labs Inc, valued at $18,663 using the latest closing price.

DODD DAVID A, the President, CEO of Geovax Labs Inc, purchase 520 shares at $2.15 during a trade that took place back on Feb 21 ’24, which means that DODD DAVID A is holding 10,452 shares at $1,118 based on the most recent closing price.

Stock Fundamentals for GOVX

Current profitability levels for the company are sitting at:

  • -257.36 for the present operating margin
  • 0.29 for the gross margin

The net margin for Geovax Labs Inc stands at -247.65. The total capital return value is set at -4.64. Equity return is now at value -160.47, with -127.82 for asset returns.

Currently, EBITDA for the company is -26.67 million with net debt to EBITDA at 0.24. When we switch over and look at the enterprise to sales, we see a ratio of -26.33. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.24.

Conclusion

In conclusion, Geovax Labs Inc (GOVX) has seen bad performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.

Related Posts